Idexx Laboratories
IDXX
573 hedge funds and large institutions have $12.8B invested in Idexx Laboratories in 2017 Q3 according to their latest regulatory filings, with 48 funds opening new positions, 175 increasing their positions, 234 reducing their positions, and 49 closing their positions.
15.91% more ownership
Funds ownership: 87.67% → 103.58% (+16%)
2% more capital invested
Capital invested by funds: $12.5B → $12.8B (+$295M)
2% less first-time investments, than exits
New positions opened: 48 | Existing positions closed: 49
9% less call options, than puts
Call options by funds: $25.9M | Put options by funds: $28.4M
2% less funds holding
Funds holding: 582 → 573 (-9)
17% less funds holding in top 10
Funds holding in top 10: 18 → 15 (-3)
25% less repeat investments, than reductions
Existing positions increased: 175 | Existing positions reduced: 234
Top Buyers
| 1 |
Fundsmith LLP
London,
United Kingdom
|
+$2.22B |
| 2 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
+$66.5M |
| 3 |
JIM
Jupiter Investment Management
London,
United Kingdom
|
+$49.3M |
| 4 |
BS
Banco Santander
Madrid,
Spain
|
+$42M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$41.6M |
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$98.4M |
| 2 |
Brown Advisory
Baltimore,
Maryland
|
-$54.6M |
| 3 |
AAM
Ardevora Asset Management
London,
United Kingdom
|
-$38.5M |
| 4 |
Charles Schwab
San Francisco,
California
|
-$35.3M |
| 5 |
William Blair Investment Management
Chicago,
Illinois
|
-$34M |
IDXX Hedge Fund Activity: Q3 2017 in Review
573 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q3 2017, worth a combined $12.8B — up 2.4% from $12.5B a quarter earlier.
Sellers outnumbered buyers: 49 funds closed out of IDXX and 48 opened new positions — a net loss of 1 holder — while 234 trimmed existing stakes and 175 added.
The largest buyer was Fundsmith LLP, adding an estimated $2.22B. The largest seller was Goldman Sachs, cutting an estimated $98.4M.
- 573 institutional investors held Idexx Laboratories (IDXX) as of Q3 2017, down from 582 in Q2 2017.
- Funds reported $12.8B of Idexx Laboratories stock for Q3 2017, up 2.4% quarter-over-quarter.
- 48 funds opened new Idexx Laboratories positions in Q3 2017 and 49 closed out, a net change of -1 holder.
- The largest Idexx Laboratories buyer in Q3 2017 was Fundsmith LLP, an estimated $2.22B added.
- The largest Idexx Laboratories seller in Q3 2017 was Goldman Sachs, an estimated $98.4M sold.
Based on aggregated 13F filings for Q3 2017.